-
DOJ Greenlights Strikes on Drug Boats, Citing Fentanyl as Potential Chemical Weapon
Saturday, November 15, 2025 - 3:51pm | 381Read More...The Justice Department has classified Fentanyl, a synthetic opioid, as a potential chemical weapon. This classification has led to the authorization of strikes on drug-smuggling boats. What Happened: The Justice Department’s classified brief, prepared by its Office of Legal Counsel, provides...
-
Elon Musk Denies Ketamine Allegations: 'If This BS From NYT Were True, It Would Have Been Extremely Obvious'
Saturday, May 31, 2025 - 12:29pm | 492Read More...Elon Musk took to X to criticize a recent New York Times report alleging he frequently used ketamine during the 2024 campaign. What Happened: On Friday, Musk responded to a comment by Pierre Ferragu, who called the New York Times’ piece on Musk “pathetic.” Musk agreed with Ferragu...
-
Ozempic: Unexpected Anti-Aging Miracle Drug? Researchers Reveal Surprising Potential
Saturday, August 31, 2024 - 3:30pm | 534Read More...Researchers are now suggesting that a drug for Type 2 diabetes and obesity might actually have anti-aging powers. Harlan Krumholz of the Yale School of Medicine declared that semaglutide, marketed as Ozempic, could be a game-changer with benefits far beyond our wildest dreams after several...
-
EXCLUSIVE: Revolutionary Alzheimer's Drug By IGC Shows Early Success
Wednesday, March 20, 2024 - 2:02pm | 878Read More...In a massive stride towards Alzheimer’s treatment, IGC Pharma (NYSE:IGC) recently revealed promising interim results for their pioneering drug, IGC-AD1, aimed at mitigating agitation in Alzheimer’s patients. This breakthrough is a beacon of hope for millions affected by this...
-
These Three Speculative Small Caps Are Loved By Insiders and Institutions
Thursday, August 22, 2013 - 11:55am | 354Read More...Small-cap pharmaceutical companies are as risky as they come. To combat this, investors look at how insiders and institutions are playing these firms with their significant expertise and inside scoop. Anacor Pharmaceuticals (NASDAQ: ANAC) develops small molecule therapeutics, the majority of...






